Cargando…
Dexamethasone can potentiate the anti-emetic action of a 5HT3 receptor antagonist on cyclophosphamide induced vomiting in the ferret.
A new group of selective 5HT3 antagonists are proving to be effective anti-emetics for cytotoxic and radiation induced vomiting in both animal models and man. Current anti-emetic regimens often benefit from combination therapy, in particular the efficacy of metoclopramide (which can be a weak 5HT3 a...
Autores principales: | Hawthorn, J., Cunningham, D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971346/ https://www.ncbi.nlm.nih.gov/pubmed/2137008 |
Ejemplares similares
-
Vomiting: The Action and Use of Emetics
Publicado: (1843) -
Megestrol acetate dispersible tablets with a 5-HT3 receptor antagonist and dexamethasone vs. 5-HT3 receptor antagonist plus dexamethasone, can better control chemotherapy-induced nausea and vomiting: a randomized controlled study
por: Ma, Yijie, et al.
Publicado: (2022) -
Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonist.
por: Cassidy, J., et al.
Publicado: (1988) -
5-Hydroxytryptamine-3 receptor antagonist and dexamethasone as prophylaxis for chemotherapy-induced nausea and vomiting during moderately emetic chemotherapy for solid tumors: a multicenter, prospective, observational study
por: Matsui, Reiko, et al.
Publicado: (2020) -
Role of dexamethasone dosage in combination with 5-HT(3) antagonists for prophylaxis of acute chemotherapy-induced nausea and vomiting
por: Münstedt, K, et al.
Publicado: (1999)